| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Thomas Wichmann, Hagai Bergman, Mahlon R DeLon. Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research. Journal of neural transmission (Vienna, Austria : 1996). vol 125. issue 3. 2019-09-27. PMID:28601961. |
thus, these interventions probably do not counteract specific aspects of the pathophysiology of movement disorders, but non-specifically remove the influence of the different types of disruptive basal ganglia output from the relatively intact portions of the motor circuitry downstream from the basal ganglia. |
2019-09-27 |
2023-08-13 |
Not clear |
| Yoland Smith, Adriana Galva. Non-human primate research of basal ganglia and movement disorders: advances and challenges. Journal of neural transmission (Vienna, Austria : 1996). vol 125. issue 3. 2019-09-27. PMID:29423879. |
non-human primate research of basal ganglia and movement disorders: advances and challenges. |
2019-09-27 |
2023-08-13 |
Not clear |
| Andreas Bay Kønig, Chiara Ciriachi, Ulrik Gether, Mattias Rickha. Chemogenetic Targeting of Dorsomedial Direct-pathway Striatal Projection Neurons Selectively Elicits Rotational Behavior in Mice. Neuroscience. vol 401. 2019-07-23. PMID:30668973. |
the striatum of the basal ganglia is pivotal for voluntary movements and is implicated in debilitating movement disorders such as parkinsonism and dystonia. |
2019-07-23 |
2023-08-13 |
mouse |
| Josef Finsterer, Elmano Henrique Torres de Carvalh. Cerebral Manifestations of Mitochondrial Disorders. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 44. issue 6. 2019-05-28. PMID:29391077. |
the most well-known cerebral manifestations of mids include stroke-like episodes, epilepsy, headache, ataxia, movement disorders, hypopituitarism, muscle weakness, psychiatric abnormalities, nystagmus, white and gray matter lesions, atrophy, basal ganglia calcification, and hypometabolism on 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron-emission tomography. |
2019-05-28 |
2023-08-13 |
Not clear |
| Yi-Jun Chen, Yu-Chao Chen, Hai-Lin Dong, Li-Xi Li, Wang Ni, Hong-Fu Li, Zhi-Ying W. Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration. Parkinsonism & related disorders. vol 49. 2019-05-23. PMID:29454663. |
phospholipase a2-associated neurodegeneration (plan) is an autosomal recessive movement disorder with abnormal iron deposition in basal ganglia, substantial nigra and adjacent areas, and cerebellar atrophy. |
2019-05-23 |
2023-08-13 |
Not clear |
| Hiroshi Sakum. [Autoantibodies Associated with Autoimmune Basal Ganglia Disorders]. Brain and nerve = Shinkei kenkyu no shinpo. vol 70. issue 4. 2019-05-10. PMID:29632284. |
autoimmune basal ganglia disorders (abgds) are presumed autoimmune encephalitides characterized by movement disorders and basal ganglia lesions on neuroimaging. |
2019-05-10 |
2023-08-13 |
Not clear |
| Brad A Racette, Anat Gross, Susan R Criswell, Harvey Checkoway, Susan Searles Nielse. A screening tool to detect clinical manganese neurotoxicity. Neurotoxicology. vol 64. 2019-03-21. PMID:28274800. |
manganese (mn) over-exposure in occupational settings is associated with basal ganglia toxicity and a movement disorder characterized by parkinsonism (i.e., the signs and symptoms of parkinson disease). |
2019-03-21 |
2023-08-13 |
Not clear |
| Manal Nicolas-Jilwa. Recessive congenital methemoglobinemia type II: Hypoplastic basal ganglia in two siblings with a novel mutation of the cytochrome b5 reductase gene. The neuroradiology journal. vol 32. issue 2. 2019-03-19. PMID:30614390. |
our patient cases highlight that basal ganglia hypoplasia is an interesting clue to the very rare and frequently unsuspected diagnosis of recessive congenital methemoglobinemia type ii, that may explain the associated movement disorders. |
2019-03-19 |
2023-08-13 |
Not clear |
| Bahman Jabbari, Nosratola D Vazir. The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodialysis international. International Symposium on Home Hemodialysis. vol 22. issue 2. 2019-03-04. PMID:28799704. |
subcortical pathology especially when it affects the basal ganglia causes a number of movement disorders including parkinsonism, chorea and dystonia. |
2019-03-04 |
2023-08-13 |
Not clear |
| Clemens Neudorfer, Mohammad Maarou. Neuroanatomical background and functional considerations for stereotactic interventions in the H fields of Forel. Brain structure & function. vol 223. issue 1. 2019-02-22. PMID:29152666. |
given the current understanding of basal ganglia involvement in movement disorders and neuropsychiatric disease we sought to investigate the h fields of forel as a potential target in stereotactic functional neurosurgery. |
2019-02-22 |
2023-08-13 |
Not clear |
| Francesca Pagani, Akansha Trivedi, Deepak Khatri, Daniela Zizioli, Emirena Garrafa, Stefania Mitola, Dario Finazz. Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis. Molecular medicine reports. vol 18. issue 5. 2019-02-12. PMID:30221726. |
mutations in these genes lead to severe and progressive movement disorders, with neurodegeneration and iron accumulation in the basal ganglia, known as pank2‑ and coasy protein‑associated neurodegeneration, respectively. |
2019-02-12 |
2023-08-13 |
human |
| b' Pavao Jurinovi\\xc4\\x87, Eni Jadrijevi\\xc4\\x87, Ana Repi\\xc4\\x87-Buli\\xc4\\x8di\\xc4\\x87, Marina Titli\\xc4\\x8. Chorea Caused by Unruptured Arteriovenous Malformation: Case Report and Review of Literature. Acta clinica Croatica. vol 56. issue 3. 2019-01-29. PMID:29479924.' |
chorea is a movement disorder that can be caused by a large range of degenerative, vascular, metabolic and toxic disorders in basal ganglia. |
2019-01-29 |
2023-08-13 |
Not clear |
| Navnika Gupta, Sanjay Pande. Post-Thalamic Stroke Movement Disorders: A Systematic Review. European neurology. vol 79. issue 5-6. 2019-01-23. PMID:29870983. |
after a stroke, movement disorders are rare manifestations mainly affecting the deep structures of the brain like the basal ganglia (44%) and thalamus (37%), although there have been case studies of movement disorders in strokes affecting the cerebral cortex also. |
2019-01-23 |
2023-08-13 |
Not clear |
| Shoko Komatsuzaki, Raga Deepthi Ediga, Jürgen G Okun, Stefan Kölker, Sven W Saue. Impairment of astrocytic glutaminolysis in glutaric aciduria type I. Journal of inherited metabolic disease. vol 41. issue 1. 2018-12-18. PMID:29098534. |
untreated patients develop bilateral lesions of basal ganglia resulting in a complex movement disorder with predominant dystonia in infancy and early childhood. |
2018-12-18 |
2023-08-13 |
Not clear |
| M Béreau, C Tranchan. [Movement disorders: An update]. La Revue de medecine interne. vol 39. issue 8. 2018-12-11. PMID:29050651. |
movement disorders (tremor, chorea, dystonia, tics, and myoclonus) are related to basal ganglia and/or interconnected brain areas dysfunction. |
2018-12-11 |
2023-08-13 |
Not clear |
| Elke Hattingen, Nikolaus Handke, Kirsten Cremer, Sabine Hoffjan, Guido Matthias Kuku. Clinical and Imaging Presentation of a Patient with Beta-Propeller Protein-Associated Neurodegeneration, a Rare and Sporadic form of Neurodegeneration with Brain Iron Accumulation (NBIA). Clinical neuroradiology. vol 27. issue 4. 2018-11-27. PMID:28643035. |
according to the affected basal nuclei, clinical features include extrapyramidal movement disorders and varying degrees of intellectual disability status. |
2018-11-27 |
2023-08-13 |
Not clear |
| Arash Fazl, Jori Fleishe. Anatomy, Physiology, and Clinical Syndromes of the Basal Ganglia: A Brief Review. Seminars in pediatric neurology. vol 25. 2018-10-29. PMID:29735113. |
movement disorders typically arise from dysfunction of the basal ganglia (bg), cerebellum, or both. |
2018-10-29 |
2023-08-13 |
Not clear |
| Fei Liu, Jiang Wang, Chen Liu, Huiyan Li, Bin Deng, Chris Fietkiewicz, Kenneth A Lopar. A neural mass model of basal ganglia nuclei simulates pathological beta rhythm in Parkinson's disease. Chaos (Woodbury, N.Y.). vol 26. issue 12. 2018-09-11. PMID:28039987. |
an increase in beta oscillations within the basal ganglia nuclei has been shown to be associated with movement disorder, such as parkinson's disease. |
2018-09-11 |
2023-08-13 |
Not clear |
| Bhagwant R Mittal, Apurva Sood, Jaya Shukla, Rakhee Vatsa, Priya Bhusari, Ritu Shree, Sahil Mehta, Manoj Goyal, Manish Mod. 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes. Nuclear medicine communications. vol 39. issue 4. 2018-08-24. PMID:29381583. |
parkinson's disease (pd) and parkinson plus syndromes (pps) are neurodegenerative movement disorders caused by loss of dopamine in the basal ganglia. |
2018-08-24 |
2023-08-13 |
Not clear |
| Tomotaka Shiraishi, Renpei Sengoku, Shigehiko Takanashi, Mari Shibukawa, Kazutomi Kanemaru, Shigeo Murayam. [Chorea due to chronic subdural hematoma]. Rinsho shinkeigaku = Clinical neurology. vol 58. issue 6. 2018-08-10. PMID:29863098. |
the rarity of these movement disorders due to csdh indicates that these patients had a preclinical dysfunction within neuronal networks interconnecting basal ganglia the cerebral cortex. |
2018-08-10 |
2023-08-13 |
Not clear |